The global Hormonal Implants market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 5.3% throughout the estimate period from 2020 to 2027.
Hormonal implants are a highly effective and very safe form of birth control in the shape of a tiny tube that is placed under the skin of a woman's upper arm. The size of the implant is as small as a toothpick and are made of flexible plastic, the implant contains a type of progestin hormone that stops the ovaries from releasing eggs. Additionally, higher safety from unwanted pregnancies, suitable government programs, raising awareness of contraceptives, and the growing research & development in the market is anticipated to fuel the market growth.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Hormonal Implants market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Hormonal Implants market growth.
The global Hormonal Implants market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Bayer HealthCare
Shanghai Dahua Pharmaceuticals Co., Ltd
Merck & Co., Inc.
Allergan
Others
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
The global hormonal implants market has been segmented based on the hormone, type, distribution sector, end user, and region.
The market, based on the hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is expected to hold a major share in the market due to the wider preferability and longer durability. The market, based on, distribution sector has been further sub-segmented into a public sector and private sector. The public sector is expected to hold a major share, due to increasing adoption rates of hormonal implants in public healthcare facilities under various government regulations.
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA